KIT and heart disorder: The results of this study laid foundation for Phase I randomized clinical trial Stem Cell Infusion in Patients with Ischemic cardiOmyopathy (SCIPIO), in which patients with heart failure resulting from ischaemic heart disease were treated with intracoronary infusion of autologous c-Kit+ cells proliferated under in vitro conditions.